Rongquan Capital
VC Fund
Shanghai, China
Rongquan Capital is an investment Firm.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Rongquan Capital invests in
Stages Rongquan Capital invests in
Countries Rongquan Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Zhao Hui
|
|||
Investment Focus
Industry
- Health Care 2 (50%)
- Medical Device 2 (50%)
- FinTech 1 (25%)
- Finance 1 (25%)
- Medical 1 (25%)
Stage
- Series D 2 (50%)
- Series A 1 (25%)
- Series C 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Zhao Hui
Managing partner
|
Managing partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hygea Medical Technology
|
Hygea Medical Technology is a oncology-focused biopharma company. Hygea’s solutions cater to cancer therapies targeting diseases in the lung, liver, breast, and kidney. Hygea will continue to develop its micro-invasive and Cryo-HITTM technology. | $14.6M / Series D / Feb 15, 2023 | |
Sinovation Medical
|
Sinovation Medical focuses on developing medical robot technology and intelligent medical product innovation. | $43.1M / Series D / Dec 26, 2022 | |
SUNRATE
|
SUNRATE started in 2016 and is committed to offering intelligent global payment and treasury solutions for business clients around the globe.SUNRATE has branches in Shanghai, Hong Kong, Tokyo, Singapore, Jakarta and London, supporting clients with international business in 130+ countries. As a strategic partner with top banks like Citibank,Standard Chartered Bank, and the principal member of Mastercard and Visa, SUNRATE will continually provide one-stop digital services to global businesses. To find out more about SUNRATE, please visit: www.sunrate.com | Series C / Dec 21, 2021 | |
Reading Technology
|
Reading Technology is an R&D company that uses imaging, data, AI diagnosis, and treatment technology for heart and brain diseases. | Series A / Nov 26, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Rongquan Capital invest in?
Rongquan Capital invests primarily in Health Care, Medical Device and FinTech startups, most often at Series D and Series A stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Rongquan Capital?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Rongquan Capital?
The team at Rongquan Capital includes Zhao Hui (Managing partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
